GSK will acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa, a phase III-ready investigational specialty medicine.

Ecolab Life Sciences has opened its new US Bioprocessing Applications Laboratory in King of Prussia, Pennsylvania.

Segmed Inc., a leader in real-world imaging data for research and AI development, has appointed David Gascoigne as Chief ...

Thermo Fisher Scientific has introduced the Applied Biosystems MagMAX Pro HT NoSpin Plasmid MiniPrep Kit to address the ...

Recipharm and ProductLife Group (PLG) have joined forces to support (bio)pharmaceutical companies in accelerating time to ...

Bora Pharmaceuticals Co., Ltd., a pharmaceutical manufacturer, has appointed Jean-Baptiste (JB) Agnus as Chief Commercial ...

Hansa Biopharma AB has appointed Maria Törnsén as Chief Operating Officer (COO) and President U.S., effective May 19.

Xmoor Pharma has entered into a strategic partnership with KU Leuven to support a new cell and gene therapy hub.

Rockwell Automation, a company dedicated to industrial automation and digital transformation, has launched FactoryTalk ...

Stylus Medicine Inc., a biotechnology company dedicated to developing transformative in vivo genetic medicines, has emerged ...

Ratio has entered into an agreement with Wasatch Group to partner and construct a radiopharmaceutical research and ...

Piramal Pharma Limited has committed to a $90 million investment plan towards expanding two of its U.S. facilities.